DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Salazar DCT, Shi J, Green M. et al.
Population pharmacokinetic/pharmacodynamic (PK/PD) analysis of exposure and bleeding in edoxaban, a novel oral factor Xa inhibitor, in patients with atrial fibrillation (Abstract).
AAPS J 2009;
11: 35-42.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.